A large proportion of biomedical research and the development of therapeutics is focused on a small fraction of the human genome. In a strategic effort to map the knowledge gaps around proteins encoded by the human genome and to promote the exploration of currently understudied, but potentially druggable, proteins, the US National Institutes of Health launched the Illuminating the Druggable Genome (IDG) initiative in 2014. In this article, we discuss how the systematic collection and processing of a wide array of genomic, proteomic, chemical and disease-related resource data by the IDG Knowledge Management Center have enabled the development of evidence-based criteria for tracking the target development level (TDL) of human proteins, which indicates a substantial knowledge deficit for approximately one out of three proteins in the human proteome. We then present spotlights on the TDL categories as well as key drug target classes, including G protein-coupled receptors, protein kinases and ion channels, which illustrate the nature of the unexplored opportunities for biomedical research and therapeutic development.
Conflict of interest statement
The authors declare
Drug target ontology to classify and integrate drug discovery data.J Biomed Semantics. 2017 Nov 9;8(1):50. doi: 10.1186/s13326-017-0161-x. J Biomed Semantics. 2017. PMID: 29122012 Free PMC article.
How to Illuminate the Druggable Genome Using Pharos.Curr Protoc Bioinformatics. 2020 Mar;69(1):e92. doi: 10.1002/cpbi.92. Curr Protoc Bioinformatics. 2020. PMID: 31898878
Engineering Aspects of Olfaction.In: Persaud KC, Marco S, Gutiérrez-Gálvez A, editors. Neuromorphic Olfaction. Boca Raton (FL): CRC Press/Taylor & Francis; 2013. Chapter 1. Neuromorphic Olfaction. 2013. PMID: 26042329 Free Books & Documents. Review.
Exploring the dark genome: implications for precision medicine.Mamm Genome. 2019 Aug;30(7-8):192-200. doi: 10.1007/s00335-019-09809-0. Epub 2019 Jul 4. Mamm Genome. 2019. PMID: 31270560 Review.
Evidence Brief: The Effectiveness Of Mandatory Computer-Based Trainings On Government Ethics, Workplace Harassment, Or Privacy And Information Security-Related Topics.2014 May. In: VA Evidence Synthesis Program Evidence Briefs [Internet]. Washington (DC): Department of Veterans Affairs (US); 2011–. VA Evidence Synthesis Program Evidence Briefs. 2011–. PMID: 27606391 Free Books & Documents. Review.
Cited by 30 articles
Critical Assessment of Targeted Protein Degradation as a Research Tool and Pharmacological Modality.Trends Pharmacol Sci. 2020 May;41(5):305-317. doi: 10.1016/j.tips.2020.02.006. Epub 2020 Mar 26. Trends Pharmacol Sci. 2020. PMID: 32222318 Review.
Cell-Free Protein Synthesis: A Promising Option for Future Drug Development.Version 2. BioDrugs. 2020 Jun;34(3):327-348. doi: 10.1007/s40259-020-00417-y. BioDrugs. 2020. PMID: 32198631 Free PMC article. Review.
Development of a CDK10/CycM in vitro Kinase Screening Assay and Identification of First Small-Molecule Inhibitors.Front Chem. 2020 Feb 27;8:147. doi: 10.3389/fchem.2020.00147. eCollection 2020. Front Chem. 2020. PMID: 32175313 Free PMC article.
High Fidelity of Mouse Models Mimicking Human Genetic Skeletal Disorders.Front Endocrinol (Lausanne). 2020 Feb 4;10:934. doi: 10.3389/fendo.2019.00934. eCollection 2019. Front Endocrinol (Lausanne). 2020. PMID: 32117046 Free PMC article. Review.
Zmat2 in mammals: conservation and diversification among genes and Pseudogenes.BMC Genomics. 2020 Jan 31;21(1):113. doi: 10.1186/s12864-020-6506-3. BMC Genomics. 2020. PMID: 32005145 Free PMC article.
- U01 MH104999/MH/NIMH NIH HHS/United States
- P30 CA118100/CA/NCI NIH HHS/United States
- U24 CA224370/CA/NCI NIH HHS/United States
- UL1 TR001449/TR/NCATS NIH HHS/United States
- P50 CA058223/CA/NCI NIH HHS/United States
- R01 CA177993/CA/NCI NIH HHS/United States
- U01 MH105026/MH/NIMH NIH HHS/United States
- U24 DK116214/DK/NIDDK NIH HHS/United States
- U24 TR002278/TR/NCATS NIH HHS/United States
- UM1 HG006370/HG/NHGRI NIH HHS/United States
- U01 MH104984/MH/NIMH NIH HHS/United States
- U54 CA189201/CA/NCI NIH HHS/United States
- Wellcome Trust/United Kingdom
- U01 MH105028/MH/NIMH NIH HHS/United States
- U24 DK116195/DK/NIDDK NIH HHS/United States
- U24 CA224260/CA/NCI NIH HHS/United States
- U54 CA189205/CA/NCI NIH HHS/United States
- U24 DK116204/DK/NIDDK NIH HHS/United States
- U01 MH104974/MH/NIMH NIH HHS/United States